Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2023)
Definium Therapeutics (DFTX) posted quarterly Net Equity Issued and Repurchased of $2.6 million for Q4 2023, up 254.25% year-over-year from $730000.0 in Q4 2022, and down 16.58% quarter-over-quarter from $3.1 million in Q3 2023.
Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends
Definium Therapeutics (DFTX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $2.6 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Net Equity Issued and Repurchased rose 254.25% year-over-year to $2.6 million; the TTM figure through Sep 2025 stood at $2.6 million (down 62.98% YoY), while the FY2024 annual figure was $984000.0, down 86.93% from the prior year.
- Net Equity Issued and Repurchased eased to $2.6 million in Q4 2023 per DFTX's latest filing, from $3.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $82.1 million in Q1 2021 and bottomed at -$185000.0 in Q2 2021.
- Historically, Net Equity Issued and Repurchased has averaged $13.1 million across 3 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased soared 687600.0% — and 2023, when it plunged 88.73%.
- Definium Therapeutics' Net Equity Issued and Repurchased stood at -$4000.0 in 2021, then jumped by 18350.0% to $730000.0 in 2022, then surged by 254.25% to $2.6 million in 2023.
- Business Quant data shows DFTX's Net Equity Issued and Repurchased at $2.6 million in Q4 2023, $3.1 million in Q3 2023, and $1.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.59 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 583,000.00 |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 730,000.00 |
| Dec 31, 2022 | 730,000.00 |
| Sep 30, 2022 | 27.50 Mn |
| Sep 30, 2022 | 27.50 Mn |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Mar 31, 2021 | 82.11 Mn |
| Mar 31, 2021 | 82.11 Mn |